Skip to main content

Monoclonal Antibody Treatment for COVID-19 at Pioneer Memorial Hospital

Monoclonal Antibodies for COVID-19 at Pioneer Memorial Hospital:

  • Early treatment with monoclonal antibodies may prevent progression to more severe disease and hospitalization
  • Monoclonal antibodies are proteins produced in a lab to target and attack specific antigens, such as the Covid-19 virus
  • Once inside your body, the monoclonal antibodies attach themselves to the Covid-19 antigen, and engage your immune system to target and attack the virus
  • Patient data from clinical trials showed that high risk Covid-19 patients treated with monoclonal antibodies had a 70% reduction in relative risk of progression to severe disease or hospitalization compared to patients who did not receive monoclonal antibodies
  • Outpatient one-time dose
  • Treatments are generally available at little or no cost to eligible patients

Patients may be eligible for treatment who:

  • Have mild to moderate symptoms of Covid-19, and
  • Have tested positive for Covid-19, and
  • Have had symptoms for 10 days or less (the treatment is most effective when given shortly after symptoms appear, so it is important to get tested and treated as soon as possible), and
  • Are at high risk of getting more serious symptoms


Click Here for More Information

Contact your MCHD provider for more information regarding Monoclonal Antibody Therapy for COVID-19.

Join our mailing list